US Stock MarketDetailed Quotes
XAIR Beyond Air
- 0.566
- -0.101-15.14%
Close Nov 27 16:00 ET
- 0.590
- +0.024+4.24%
Post 20:01 ET
40.86MMarket Cap-401P/E (TTM)
0.660High0.510Low1.59MVolume0.660Open0.667Pre Close915.51KTurnover3.26%Turnover RatioLossP/E (Static)72.19MShares2.36052wk High1.45P/B27.57MFloat Cap0.29652wk Low--Dividend TTM48.70MShs Float16.410Historical High--Div YieldTTM22.53%Amplitude0.296Historical Low0.577Avg Price1Lot Size
About Beyond Air Company
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Company Profile
SymbolXAIR
Company NameBeyond Air
Listing DateMay 7, 2019
Founded2015
CEOMr. Steven A. Lisi
MarketNASDAQ
Employees107
Fiscal Year Ends03-31
Address900 Stewart Avenue,Suite 301
CityGarden City
ProvinceNew York
CountryUnited States of America
Zip Code11530
Phone1-516-665-8200
Websitehttp://www.beyondair.net
Company Executives
- Name
- Position
- Salary
- Amir Avniel
- President, Beyond Air Ltd and Chief Executive Officer of NeuroNOS Israel Limited
- 952.00K
- Steven A. Lisi
- Chairman of the Board and Chief Executive Officer
- 1.73M
- Michael Gaul
- Chief Operating Officer
- 799.00K
- Douglas Quinton Larson
- Chief Financial Officer and Principal Accounting Officer
- --
- Robert F. Carey
- Independent Director
- 102.60K
- Erick J. Lucera, C.F.A.
- Independent Director
- 51.30K
- Dr. William P. Forbes
- Independent Director
- 51.30K
- Yoori Lee
- Independent Director
- 51.30K
- Ron Bentsur
- Independent Director
- 51.30K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data